Delivery Order SPE2DB22D2206-SPE2DB24FFS09
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $9,845.46 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide MONOVISC 88 MG/4 ML SYRINGE 4ML. This delivery order contract is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA to deliver a comprehensive range of pharmaceutical products and medical supplies to military treatment...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $4,647.12 to provide MONOVISC 88 MG/4 ML SYRINGE 4ML medical supplies. This delivery order was issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, that serves as the primary vehicle for the company to deliver pharmaceutical products and medical...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $4,647.12 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,288,309 units of MONOVISC 88 MG/4 ML SYRINGE 4ML. This contract has an ultimate completion date of April 16, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle...
- The U.S. Defense Logistics Agency (DLA) awarded a $5,268.40 firm fixed-price delivery order to Amerisourcebergen Drug Corporation's Corporate Office Division for the supply of 4,565,285,746 units of the MONOVISC 88 MG/4 ML SYRINGE 4ML medical product. This delivery order was issued under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $4,647.12 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, with a period of performance through May 31, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract worth $5,002.83 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, on a firm fixed-price basis. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $4,647.12 to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, with a period of performance through May 31, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....
- Amerisourcebergen Drug Corp, a for-profit organization, was awarded a $2,313.29 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. The contract has a completion date of February 9, 2024. Amerisourcebergen Drug Corp is the prime contractor and this order is part of a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, that serves as the primary...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $4,647.12 contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a specialty medical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $5,300.69 firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical to provide MONOVISC 88 MG/4 ML SYRINGE 4ML medical supplies. The delivery order has a completion date of February 13, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, including the Department of...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FFS09Delivery Order
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract worth $4,647.12 by the Defense Logistics Agency (DLA) to provide MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and medical facilities worldwide. The IDC has a potential value of $999,999,999.00 and a performance period through December 31, 2025. No set-aside designation was used for this contract, which is intended to meet the medical supply needs of the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 2/20/24 |